Követés
Sándor Somodi
Sándor Somodi
University of Debrecen
E-mail megerősítve itt: belklinika.com
Cím
Hivatkozott rá
Hivatkozott rá
Év
The impact of obesity on the cardiovascular system
I Csige, D Ujvárosy, Z Szabó, I Lőrincz, G Paragh, M Harangi, S Somodi
Journal of diabetes research 2018, 2018
5322018
Association of chemerin with oxidative stress, inflammation and classical adipokines in non‐diabetic obese patients
P Fülöp, I Seres, H Lőrincz, M Harangi, S Somodi, G Paragh
Journal of cellular and molecular medicine 18 (7), 1313-1320, 2014
852014
Margatoxin is a non-selective inhibitor of human Kv1. 3 K+ channels
A Bartok, A Toth, S Somodi, TG Szanto, P Hajdu, G Panyi, Z Varga
Toxicon 87, 6-16, 2014
822014
Anuroctoxin, a new scorpion toxin of the α-KTx 6 subfamily, is highly selective for Kv1. 3 over IKCa1 ion channels of human T lymphocytes
M Bagdáany, CVF Batista, NA Valdez-Cruz, S Somodi, RCR de la Vega, ...
Molecular pharmacology 67 (4), 1034-1044, 2005
762005
pH-dependent modulation of Kv1. 3 inactivation: role of His399
S Somodi, Z Varga, P Hajdu, JG Starkus, DI Levy, R Gáspár, G Panyi
American Journal of Physiology-Cell Physiology 287 (4), C1067-C1076, 2004
562004
Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects
H Lőrincz, M Katkó, M Harangi, S Somodi, K Gaál, P Fülöp, G Paragh, ...
Clinical endocrinology 81 (3), 370-377, 2014
452014
Novel α-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1. 3 over IKCa1 K+ channels of T cells
T Olamendi-Portugal, S Somodi, JA Fernández, FZ Zamudio, B Becerril, ...
Toxicon 46 (4), 418-429, 2005
432005
Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese nondiabetic subjects
S Somodi, I Seres, H Lőrincz, M Harangi, P Fülöp, G Paragh
International Journal of Endocrinology 2018, 2018
322018
7DHC-induced changes of Kv1. 3 operation contributes to modified T cell function in Smith-Lemli-Opitz syndrome
A Balajthy, S Somodi, Z Pethő, M Péter, Z Varga, GP Szabó, G Paragh, ...
Pflügers Archiv-European Journal of Physiology 468, 1403-1418, 2016
242016
Insulin-sensitizer effects of fenugreek seeds in parallel with changes in plasma MCH levels in healthy volunteers
R Kiss, K Szabó, R Gesztelyi, S Somodi, P Kovács, Z Szabó, J Németh, ...
International journal of molecular sciences 19 (3), 771, 2018
212018
New phenotypic, functional and electrophysiological characteristics of KG-1 cells
G Hajas, E Zsiros, T László, P Hajdú, S Somodi, B Réthi, P Gogolák, ...
Immunology letters 92 (1-2), 97-106, 2004
212004
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile
B Ratku, V Sebestyén, A Erdei, EV Nagy, Z Szabó, S Somodi
Pituitary 25 (2), 211-228, 2022
172022
Mannose-binding lectin levels and carotid intima-media thickness in type 2 diabetic patients
M Káplár, S Sweni, J Kulcsár, B Cogoi, R Esze, S Somodi, M Papp, L Oláh, ...
Journal of diabetes research 2016, 2016
162016
Analysis of the K+ current in human CD4+ T lymphocytes in hypercholesterolemic state
S Somodi, A Balajthy, O Szilágyi, Z Pethő, M Harangi, G Paragh, G Panyi, ...
Cellular immunology 281 (1), 20-26, 2013
152013
Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients
A Szentpéteri, H Lőrincz, S Somodi, VE Varga, G Paragh, I Seres, ...
Lipids in Health and Disease 17, 1-8, 2018
142018
Age, BMI and diabetes as independent predictors of brain hypoperfusion
Z Képes, F Nagy, Á Budai, S Barna, R Esze, S Somodi, M Káplár, I Garai, ...
Nuclear Medicine Review 24 (1), 11-15, 2021
132021
Effects of changes in extracellular pH and potassium concentration on Kv1. 3 inactivation
S Somodi, P Hajdu, R Gáspár, G Panyi, Z Varga
European Biophysics Journal 37, 1145-1156, 2008
132008
Metabolomic analysis of serum and tear samples from patients with obesity and type 2 diabetes mellitus
E Nokhoijav, A Guba, A Kumar, B Kunkli, G Kalló, M Káplár, S Somodi, ...
International journal of molecular sciences 23 (9), 4534, 2022
112022
Afamin levels and their correlation with oxidative and lipid parameters in non-diabetic, obese patients
I Juhász, S Ujfalusi, I Seres, H Lőrincz, VE Varga, G Paragh Jr, S Somodi, ...
Biomolecules 12 (1), 116, 2022
112022
The anti-proliferative effect of cation channel blockers in T lymphocytes depends on the strength of mitogenic stimulation
Z Petho, A Balajthy, A Bartok, K Bene, S Somodi, O Szilagyi, ...
Immunology letters 171, 60-69, 2016
112016
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20